Charles Schwab Investment Management Inc. Has $3.12 Million Stock Holdings in Aspen Aerogels, Inc. $ASPN

Charles Schwab Investment Management Inc. trimmed its stake in Aspen Aerogels, Inc. (NYSE:ASPN) by 11.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 487,731 shares of the construction company’s stock after selling 61,978 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.59% of Aspen Aerogels worth $3,117,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of ASPN. Banque Cantonale Vaudoise acquired a new stake in Aspen Aerogels in the first quarter worth $45,000. Exchange Traded Concepts LLC grew its holdings in Aspen Aerogels by 460.4% in the first quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company’s stock worth $48,000 after purchasing an additional 6,109 shares during the period. CWM LLC grew its holdings in Aspen Aerogels by 2,137.9% in the first quarter. CWM LLC now owns 8,325 shares of the construction company’s stock worth $53,000 after purchasing an additional 7,953 shares during the period. Teacher Retirement System of Texas acquired a new stake in Aspen Aerogels in the first quarter worth $65,000. Finally, Sandia Investment Management LP acquired a new position in shares of Aspen Aerogels during the fourth quarter valued at about $89,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CAO Santhosh P. Daniel sold 4,410 shares of the business’s stock in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total value of $32,237.10. Following the sale, the chief accounting officer owned 19,879 shares of the company’s stock, valued at $145,315.49. The trade was a 18.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 4.30% of the stock is currently owned by company insiders.

Aspen Aerogels Stock Performance

NYSE ASPN opened at $6.83 on Friday. The company’s 50 day moving average is $7.01 and its 200-day moving average is $6.62. Aspen Aerogels, Inc. has a 12-month low of $4.16 and a 12-month high of $30.24. The company has a quick ratio of 3.31, a current ratio of 3.98 and a debt-to-equity ratio of 0.34. The firm has a market cap of $562.52 million, a P/E ratio of -1.79 and a beta of 2.73.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Thursday, August 7th. The construction company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.08. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The company had revenue of $78.02 million for the quarter, compared to analyst estimates of $72.53 million. During the same quarter in the previous year, the firm posted $0.21 earnings per share. The company’s quarterly revenue was down 33.8% compared to the same quarter last year. Aspen Aerogels has set its FY 2025 guidance at -3.860–3.730 EPS. Sell-side analysts predict that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on ASPN shares. Barclays cut shares of Aspen Aerogels from an “equal weight” rating to an “underweight” rating and lifted their price objective for the company from $7.00 to $16.00 in a report on Monday, August 11th. Canaccord Genuity Group reduced their price objective on shares of Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating for the company in a report on Friday, August 8th. Finally, Oppenheimer cut shares of Aspen Aerogels from an “outperform” rating to a “market perform” rating in a report on Thursday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $19.50.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.